Growth Metrics

Lemaitre Vascular (LMAT) Short term Debt (2020 - 2021)

Lemaitre Vascular (LMAT) reported Short term Debt of $3.0 million for Q2 2021, down 88.0% year-over-year from $25.0 million in Q2 2020, and up 9.09% on a QoQ basis from $2.8 million in Q1 2021.

Lemaitre Vascular (LMAT) has 2 years of Short term Debt data on file, last reported at $3.0 million in Q2 2021.

  • Quarterly Short term Debt fell 88.0% year-over-year to $3.0 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $3.0 million (down 88.0% YoY) and the FY2020 annual result came in at $2.5 million, changed N/A from the prior year.
  • Short term Debt rose to $3.0 million in Q2 2021 per LMAT's latest filing, from $2.8 million in the prior quarter.
  • Across five years, Short term Debt topped out at $25.0 million in Q2 2020 and bottomed at $2.5 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 3.00 Mn
Mar 31, 2021 2.75 Mn
Dec 31, 2020 2.50 Mn
Sep 30, 2020 21.00 Mn
Jun 30, 2020 25.00 Mn